Alluvium Biosciences

Ann Arbor, United States Founded: 2009 • Age: 17 yrs
Specializes as a preclinical CRO, developing high-value small molecules derived from natural sources for clients.
Annual revenue - Latest available
Total funding - 4 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Alluvium Biosciences

Alluvium Biosciences is a company based in Ann Arbor (United States) founded in 2009. It operates as a B2B. Alluvium Biosciences operates in a competitive market with competitors including AnalytiCon Discovery, Magellan BioScience Group, C2 Pharma, Celtarys and BJ Biochem, among others.

  • Headquarter Ann Arbor, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $224.91 K (USD), Grant

    May 17, 2016

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Alluvium Biosciences

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $224,910
  • First Round

    (11 Aug 2009)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2016 Amount Grant - Alluvium Biosciences Valuation

investors

HHS
May, 2012 Amount Grant - Alluvium Biosciences Valuation

investors

HHS
Sep, 2010 Amount Grant - Alluvium Biosciences Valuation

investors

HHS

Investors in Alluvium Biosciences

Alluvium Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location

Investments & Acquisitions by Alluvium Biosciences

Investments

Financial Statements - Alluvium Biosciences

Alluvium Biosciences Comparisons

+
Add Comparison
Available on Premium

Competitors of Alluvium Biosciences

Alluvium Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, Magellan BioScience Group, C2 Pharma, Celtarys and BJ Biochem, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Natural products chemistry is specialized in by AnalytiCon Discovery.
domain founded_year HQ Location
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
domain founded_year HQ Location
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
domain founded_year HQ Location
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery
domain founded_year HQ Location
Research and development services for sugar derivatives are provided.
domain founded_year HQ Location
Develops technologies to harness compounds from natural production.

Latest news on Alluvium Biosciences

Frequently Asked Questions about Alluvium Biosciences

Alluvium Biosciences was founded in 2009.

Alluvium Biosciences is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.

Alluvium Biosciences specializes as a preclinical cro, developing high-value small molecules derived from natural sources for clients, focusing on advancing biotech innovations, producing pharmaceutical products, drug development, and small molecules. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Alluvium Biosciences's top competitors include AnalytiCon Discovery, BJ Biochem and Magellan BioScience Group.

Alluvium Biosciences has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available